Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR
No-Receipt date
2012-01902 - 15/06/2012
No-Filing date
20120401376 - 15/06/2012
No-Granting date
3078249 - 18/06/2012
No-EPO application date
06837238.2 - 07/11/2006
No-EPO granting date
1948608 - 14/03/2012
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2012 - 13/07/2012
Expiration date
08/11/2026
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US735224 P08/11/2005/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 213/75
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
415070
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
984482
GRANT, CRAIG
984483
KANTER, JAMES P.
984484
LANGLANDS, GRAEME
Representatives
Code
Firstname
Surname
Address
Town
Zip
1602
AIKATERINI
SIOTOU
PATISION 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
6/7/2022 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 05 / 2022 Αρ. Πρωτ. ΓΔ 1397 / 07.06.2022
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).